Bladder preservation strategy with induction chemotherapy (CT) followed by chemoradiotherapy (CRT) in bladder cancer

被引：0
|
作者：
Ozkan, A. [1 ]
Mayadagli, A. [1 ]
Kocak, M. [1 ]
Demir, O. [1 ]
Parlak, C. [1 ]
Gul, S. K. [1 ]
机构：
[1] Dr Lutfi Kridar Kartal Educ & Res Hosp, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5081
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bladder Preservation by Neoadjuvant Chemotherapy followed by Concurrent Chemoradiotherapy with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)
    Anandadas, C.
    Thompson, C.
    Sanderson, B.
    Lyons, J.
    Stratford, J.
    Logue, J. P.
    [J]. CLINICAL ONCOLOGY, 2013, 25 (04) : E69 - E69
  • [2] Combined modality therapy (transurethral surgery, induction chemotherapy, followed by concurrent chemoradiotherapy) for bladder preservation for patients with muscle invasive bladder cancer: Preliminary report.
    Hsu, CH
    Lin, CC
    Chen, JC
    Cheng, AL
    Huang, CY
    Chen, J
    Pu, YS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 450S - 450S
  • [3] Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
    Sung, Hyun Hwan
    Kim, Hana
    Kim, Ryul
    Kim, Chan Kyo
    Kwon, Ghee Young
    Park, Won
    Song, Wan
    Jeong, Byong Chang
    Park, Se Hoon
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (02) : 168 - 174
  • [4] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
    Elsayed, Dalia Hamouda
    Elfarargy, Ola M.
    Elderey, Mohamed Salah
    Mandour, Doaa
    Atef, Nora
    Hemeda, Rehab
    Kamel, Mostafa
    Azony, Ahmed
    Taha, Heba F.
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
  • [5] Induction Chemotherapy Followed by Surgery in Node Positive Bladder Cancer
    Meijer, Richard P.
    Mertens, Laura S.
    van Rhijn, Bas W.
    Bex, Axel
    van der Poel, Henk G.
    Meinhardt, Wim
    Kerst, J. Martijn
    Bergman, Andre M.
    Fioole-Bruining, Annemarie
    van Werkhoven, Erik
    Horenblas, Simon
    [J]. UROLOGY, 2014, 83 (01) : 134 - 139
  • [6] Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation
    Sternberg, Cora N.
    [J]. SEMINARS IN ONCOLOGY, 2007, 34 (02) : 122 - 128
  • [7] Induction chemotherapy (CTX) followed by concurrent chemoradiotherapy (CRT) in patients (pts) with nasopharyngeal cancer (NPC).
    Choi, JH
    Lim, HY
    Park, JS
    Kim, HC
    Kang, S
    Oh, YT
    Chun, M
    Kim, CH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 512S - 512S
  • [8] Chemotherapy for bladder cancer: Treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer
    Sternberg, Cora N.
    Donat, S. Machele
    Bellmunt, Joaquim
    Millikan, Randall E.
    Stadler, Walter
    De Mulder, Pieter
    Sherif, Amir
    von der Maase, Hans
    Tsukamoto, Taiji
    Soloway, Mark S.
    [J]. UROLOGY, 2007, 69 : 62 - 79
  • [9] Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy (CRT) in muscle-invasive urothelial carcinoma of bladder (MIBC): A combined retrospective analysis of two prospective studies.
    Hong, Joohyun
    Choi, Daeho
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Park, Se Hoon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [10] Concomitant chemoradiotherapy for muscle-invasive bladder cancer: The way forward for bladder preservation?
    Sherwood, BT
    Jones, GDD
    Mellon, JK
    Kockelbergh, RC
    Steward, WP
    Symonds, RP
    [J]. CLINICAL ONCOLOGY, 2005, 17 (03) : 160 - 166
12345